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Summary
Background: The aim of this study was to evaluate the gender differences in plaque components
in acute coronary syndrome (ACS) patients.
Methods: We used virtual histology-intravascular ultrasound to evaluate the plaque components
in culprit lesions in 362 ACS patients (254 men, 108 women).
Results: Women were more likely to be diabetic (34% vs 23%, p = 0.030), had greater percentage
necrotic core (%NC) volume (19.0± 12.7% vs 16.8± 11.9%, p = 0.040), and had trends toward
higher high-sensitivity C-reactive protein (hs-CRP) (0.85± 1.28mg/dl vs 0.53± 0.48mg/dl,
p = 0.063), and higher incidence of thin-cap ﬁbroatheroma (TCFA) (62% vs 52%, p = 0.078) com-
pared with men. %NC volume was signiﬁcantly greater in diabetic patients compared with± 10.2% vs 16.0± 8.9%, p < 0.001) and was signiﬁcantly greaternondiabetic patients (20.4
in patients with elevated hs-CRP (≥0.2mg/dl) compared with those with normal hs-CRP
(<0.2mg/dl) (18.8± 8.9% vs 16.6± 9.7%, p = 0.021). However, there were no differences in
plaque components between diabetic women and men, and between women and men with ele-
vated hs-CRP levels. Diabetes [odds ratio (OR): 2.44, 95% conﬁdence interval (CI): 1.35—3.82,
p = 0.003] and hs-CRP (OR: 1.54, 95% CI: 1.08—2.65, p = 0.032), but not female gender, were the
independent predictors of TCFA.
∗ Corresponding author at: Principal Investigator of Korea Acute Myocardial Infarction Registry, Director of Heart Research Center of
Chonnam National University Hospital, 671 Jaebongro, Dong-gu, Gwangju 501-757, Republic of Korea. Tel.: +82 62 220 6243,
fax: +82 62 228 7174.
E-mail addresses:myungho@chollian.net, myungho@chol.com (M.H. Jeong).
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Conclusions: Although it seems likely that female ACS patients have more vulnerable plaque
components compared with male ACS patients, these ﬁndings may result not from true gender
differences in plaque components but higher prevalence of diabetes and hs-CRP elevation in
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coefﬁcients were 0.96, 0.97, and 0.97, respectively. Simi-
larly, for plaque components by VH-IVUS, reproducibility forwomen.
© 2010 Japanese College of C
ntroduction
oronary artery disease is the most frequent cause of mor-
ality among women [1,2]. Previous studies fully addressed
ender-related extent and localization of coronary artery
isease [3—5]. Several studies have reported gender
ifferences in the diagnosis and medical treatment of car-
iovascular disease, to the detriment of women [6—9]. On
he other hand, some other studies showed no differences
n the extent and localization of coronary artery disease
3,10,11].
Women develop coronary artery disease later in life than
en. This difference has been attributed to the loss of
emale sex hormones at the time of menopause, but the bio-
ogical explanations for gender differences in cardiovascular
iseases are more complex [12]. Mechanisms for cardiovas-
ular gender differences have not yet been proved, and it
s not well known about the gender differences in plaque
omponents. Therefore, the aim of the present study was
o evaluate whether there would be gender-related differ-
nces in terms of the composition of coronary artery plaques
n patients with acute coronary syndrome (ACS) using virtual
istology-intravascular ultrasound (VH-IVUS).
ethods
tudy population
his study was a retrospective, single-center study. A total
f 2580 patients with ACS were admitted to our insti-
ute from February 2007 to January 2009. We excluded
atients with stent thrombosis, restenosis after stenting,
oronary artery bypass graft failure, severe heart failure
r cardiogenic shock, important systemic disease, serum
reatinine ≥2.5mg/dl, any concomitant infection which
ould falsely increase high-sensitivity C-reactive protein (hs-
RP), and patients in whom adequate IVUS images could
ot be obtained. Finally, we identiﬁed 362 consecutive ACS
atients who underwent pre-intervention VH-IVUS within
4 h of symptom onset. The presence of unstable angina was
etermined by chest pain within the preceding 72 h with or
ithout ST-T wave changes or positive cardiac biochemical
arkers (creatine kinase-MB or cardiac-speciﬁc troponin-I).
he presence of ST-segment elevation myocardial infarc-
ion was determined by >30min of continuous chest pain,
new ST-segment elevation ≥2mm on at least two con-
iguous electrocardiographic leads, and creatine kinase-MB
3 times normal. The presence of non-ST-segment eleva-
ion myocardial infarction was diagnosed by chest pain and
ositive cardiac biochemical markers (creatine kinase-MB or
ardiac-speciﬁc troponin-I) without new ST-segment eleva-
ion. The protocol was approved by the institutional review
oard. Hospital records of patients were reviewed to obtain
nformation on clinical demographics.
t
n
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0ology. Published by Elsevier Ireland Ltd. All rights reserved.
aboratory analysis
eripheral blood samples were obtained before coro-
ary angiography using direct venipuncture. The blood
amples were centrifuged, and serum was removed and
tored at −70 ◦C until the assay could be performed.
bsolute creatine kinase-MB levels were determined by
adioimmunoassay (Dade Behring Inc., Miami, FL, USA).
ardiac-speciﬁc troponin-I levels were measured by a para-
agnetic particle, chemiluminescent immunoenzymatic
ssay (Beckman, Coulter Inc., Fullerton, CA, USA). The
erum levels of total cholesterol, triglyceride, low-density
ipoprotein cholesterol, and high-density lipoprotein choles-
erol were measured by standard enzymatic methods.
s-CRP was analyzed turbidimetrically with sheep antibod-
es against human CRP; this has been validated against the
ade Behring method [13].
uantitative coronary angiography analysis
oronary angiogram was analyzed with a validated quanti-
ative coronary angiography (QCA) system (Philips H5000 or
llura DCI program, Philips Medical Systems, Eindhoven, The
etherlands). With the outer diameter of the contrast-ﬁlled
atheter as the calibration standard, the minimal lumen
iameter and reference diameter were measured in diastolic
rames from orthogonal projections.
ray-scale and VH-IVUS imaging and analysis
ll pre-intervention gray-scale and VH-IVUS examinations
ere performed after intracoronary administration of
00g nitroglycerin. A 20-MHz, 2.9F IVUS imaging catheter
Eagle Eye, Volcano Corp., Rancho Cordova, CA, USA) was
dvanced >10mm beyond the lesion; and automated pull-
ack was performed to a point >10mm proximal to the
esion at a speed of 0.5mm/s. In patients with Thromboly-
is In Myocardial Infarction (TIMI) 0 or 1 ﬂow, we performed
hrombus aspiration or percutaneous transluminal coronary
ngioplasty with small-sized balloon at low pressure ﬁrst
efore IVUS examination.
Gray-scale IVUS and VH-IVUS data were analyzed by
wo independent observers (H.Y.J. and C.Y.H.). The lev-
ls of reproducibility for external elastic membrane (EEM),
umen, and plaque plus media (P&M), and cross-sectional
reas (CSAs) using the Spearman rank-order correlationhe ﬁbrous (FT), ﬁbro-fatty (FF), dense calcium (DC), and
ecrotic core (NC) volume measurements using the Spear-
an rank-order correlation coefﬁcients were 0.93, 0.94,
.93, and 0.93, respectively.
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Quantitative volumetric gray-scale and VH-IVUS analyses
were performed across the entire lesion segment, and cross-
sectional analyses were performed at the minimum lumen
sites and at the largest NC sites. Conventional quantitative
volumetric gray-scale IVUS analysis was performed accord-
ing to the American College of Cardiology Clinical Expert
Consensus Document on Standards for Acquisition, Mea-
surement and Reporting of Intravascular Ultrasound Studies
[14]. Measurements were made at every 1-mm interval for
the region of interest, which was deﬁned as the segment
between distal to proximal reference sites that were the
most normal looking within 5mm proximal and distal to
the lesion. Volumetric data were generated by the soft-
ware using Simpson’s method. EEM and lumen CSAs were
S
T
d
Table 1 Baseline characteristics.
Men (n = 2
Age (years) 58± 13
Clinical presentation
Unstable angina 138 (54)
NSTEMI 42 (17)
STEMI 74 (29)
Height (m) 1.72± 0.
Weight (kg) 69.1± 11
Body mass index (kg/m2) 23.4± 8.
Body surface area (m2) 1.82± 0.
Symptom to IVUS time (days) 38± 19
Diabetes mellitus 59 (23)
Hypertension 124 (49)
Smoking 133 (52)
Family history of coronary artery disease 25 (10)
Prior myocardial infarction 6 (2)
Previous PCI 14 (6)
Ejection fraction (%) 60± 9
White blood cells (103/mm3) 8.5± 3.3
Hemoglobin (g/dl) 14.3± 1.
Platelet count (103/mm3) 247± 55
Glucose (mg/dl) 142± 41
Creatine kinase-MB (U/dl) 15.5± 24
Troponin-I (ng/ml) 3.5± 13.
Creatinine (mg/dl) 0.94± 0.
hs-CRP (mg/dl) 0.53± 0.
NT-pro-BNP (pg/ml) 520± 635
Total cholesterol (mg/dl) 183± 40
Triglyceride (mg/dl) 120± 70
LDL-cholesterol (mg/dl) 119± 35
HDL-cholesterol (mg/dl) 47.9± 22
Prior medications
Aspirin 250 (98)
Clopidogrel 229 (90)
Beta-blocker 173 (68)
Calcium channel blocker 102 (40)
ACEI/ARB 152 (60)
Statin 74 (29)
Data are n (%), or mean± SD. NSTEMI, non-ST-segment elevation m
infarction; IVUS, intravascular ultrasound; PCI, percutaneous coronar
low-density lipoprotein; HDL, high-density lipoprotein; ACEI, angioten
blocker.213
easured. P&M CSA was calculated as EEM minus lumen
SA; and plaque burden was calculated as P&M divided by
EM CSA. VH-IVUS analysis classiﬁed the color-coded tissue
nto four major components: green (FT); yellow—green (FF);
hite (DC); and red (NC) [15—18]. Thin-cap ﬁbroatheroma
TCFA) was deﬁned as focal, NC-rich (≥10% of the CSA)
laques being in contact with the lumen in a plaque burden
40% [16]. VH-IVUS analysis was reported as a percentage
f plaque area or volume.tatistical analysis
he Statistical Package for Social Sciences (SPSS) for Win-
ows, version 15.0 (SPSS Inc., Chicago, IL, USA) was used
54) Women (n = 108) p value
65± 11 <0.001
0.6
54 (50)
22 (20)
32 (30)
56 1.58± 0.49 <0.001
.6 56.4± 10.9 <0.001
12 22.6± 5.23 0.028
60 1.57± 0.45 <0.001
45± 18 0.10
37 (34) 0.030
86 (80) <0.001
16 (15) <0.001
13 (12) 0.5
3 (3) 0.8
11 (10) 0.11
58± 8 0.12
8.8± 3.5 0.4
4 12.3± 1.6 <0.001
259± 117 0.3
141± 43 0.9
.4 17.4± 20.3 0.7
5 3.8± 12.8 0.4
24 0.80± 0.62 0.002
48 0.85± 1.28 0.063
353± 528 0.2
182± 47 0.9
108± 62 0.11
114± 42 0.3
.3 49.4± 10.3 0.3
105 (97) 0.9
96 (89) 0.9
69 (64) 0.4
45 (42) 0.6
59 (55) 0.3
32 (30) 0.9
yocardial infarction; STEMI, ST-segment elevation myocardial
y intervention; hs-CRP, high-sensitivity C-reactive protein; LDL,
sin converting enzyme inhibitor; and ARB, angiotensin receptor
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or all analyses. Continuous variables were presented as the
ean value± 1 SD; comparisons were conducted by stu-
ent’s t-test or the Wilcoxon rank-sum test if normality
ssumption was violated. Discrete variables were presented
s percentages and frequencies; comparisons were con-
ucted by 2 statistics or Fisher’s exact test as appropriate.
multivariable logistic regression analysis was performed to
dentify the independent predictors of culprit lesion TCFA.
p value <0.05 was considered statistically signiﬁcant.
esults
aseline characteristics
he baseline characteristics are summarized in Table 1.
omen were older, had more hypertension and diabetes,
nd were less likely to be smokers compared with men.
emoglobin and creatinine levels were signiﬁcantly lower,
nd there was a trend toward higher hs-CRP level in women
ompared with men.
ngiographic results
ngiographic ﬁndings are summarized in Table 2. There were
o signiﬁcant differences in culprit vessel, lesion location,
IMI ﬂow grade, and angiographic lesion length. However,
ultivessel disease was more common and there were
rends toward smaller angiographic reference diameter and
inimal lumen diameter in women compared with men.ray-scale IVUS results
ray-scale IVUS ﬁndings are summarized in Table 3. EEM
nd lumen CSAs at proximal and distal references were sig-
c
t
c
h
(
Table 2 Coronary angiographic ﬁndings.
Men (n = 254)
Culprit vessel
Left anterior descending 152 (60)
Left circumﬂex 41 (16)
Right 61 (24)
Lesion location
Ostium 12 (5)
Proximal 102 (40)
Middle 94 (37)
Distal 46 (18)
Multivessel disease 119 (47)
TIMI ﬂow grade
0 10 (4)
1 15 (6)
2 56 (22)
3 173 (68)
Lesion length (mm) 20± 10
Reference diameter (mm) 3.24± 0.54
Pre-MLD (mm) 0.95± 0.56
Data are n (%), or mean± SD. TIMI, Thrombolysis In Myocardial InfarctiY.J. Hong et al.
iﬁcantly smaller in women compared with men. At the
inimum lumen sites, EEM and P&M CSAs were signiﬁcantly
maller, and there was a trend toward smaller lumen CSA in
omen compared with men. At the largest NC sites, EEM,
umen, and P&M CSAs were signiﬁcantly smaller in women
ompared with men. By volumetric analysis, EEM, lumen,
nd P&M volumes were signiﬁcantly smaller in women com-
ared with men.
H-IVUS results
t the proximal reference sites, there were trends toward
reater %DC (10.9± 9.0% vs 9.3± 7.6%, p = 0.13) and %NC
reas (13.1± 9.9% vs 11.0± 9.2%, p = 0.083) and smaller
FF area (15.9± 13.9% vs 19.3± 15.8%, p = 0.062) in women
ompared with men. At the distal reference sites, there
ere trends toward greater %DC (11.2± 9.0% vs 8.9± 7.6%,
= 0.064) and %NC areas (13.8± 9.9% vs 11.0± 9.2%,
= 0.14) and smaller %FF area (15.2± 13.9% vs 18.6± 15.8%,
= 0.078) in women compared with men.
At the minimum lumen sites, %DC and %NC areas were sig-
iﬁcantly greater in women compared with men; conversely,
FT area was signiﬁcantly smaller in women compared with
en (Fig. 1A). At the largest NC sites, %NC area was sig-
iﬁcantly greater (27.2± 11.7% vs 24.6± 11.3%, p = 0.050)
ith the trend toward greater %DC area (13.8± 10.3% vs
1.9± 9.0%, p = 0.082) in women compared with men; con-
ersely, %FT area was signiﬁcantly smaller (51.2± 14.5%
s 54.6± 13.4%, p = 0.030) in women compared with men.
y volumetric analysis, %DC and %NC volumes were signiﬁ-
antly greater in women compared with men; conversely,
here was a trend toward smaller %FT volume in women
ompared with men (Fig. 1B). There was a trend toward
igher incidence of TCFA in women compared with men
62% vs 52%, p = 0.078).
Women (n = 108) p value
0.6
59 (55)
19 (18)
30 (28)
0.7
8 (7)
45 (42)
38 (35)
17 (16)
69 (64) 0.028
0.7
5 (5)
5 (5)
29 (27)
69 (64)
22± 7 0.3
3.06± 0.58 0.054
0.88± 0.55 0.063
on; and MLD, minimal lumen diameter.
Gender differences in plaque components 215
Table 3 Gray-Scale intravascular ultrasound ﬁndings.
Men (n = 254) Women (n = 108) p value
Proximal reference
EEM CSA (mm2) 18.1± 6.6 16.4± 5.7 0.032
Lumen CSA (mm2) 11.4± 4.7 10.2± 2.2 0.036
P&M CSA (mm2) 6.7± 3.3 6.2± 3.1 0.14
Plaque burden (%) 37± 8 38± 8 0.6
Minimum lumen site
EEM CSA (mm2) 17.2± 6.6 15.3± 5.3 0.001
Lumen CSA (mm2) 4.4± 3.8 3.6± 3.3 0.052
P&M CSA (mm2) 12.8± 5.7 11.7± 5.1 <0.001
Plaque burden (%) 74± 13 76± 9 0.18
Distal reference
EEM CSA (mm2) 16.3± 7.2 14.6± 6.1 0.025
Lumen CSA (mm2) 10.2± 4.5 9.2± 3.8 0.031
P&M CSA (mm2) 6.2± 3.4 5.6± 2.7 0.11
Plaque burden (%) 37± 8 37± 7 0.6
Largest necrotic core site
EEM CSA (mm2) 17.0± 7.2 14.5± 5.7 0.002
Lumen CSA (mm2) 6.0± 4.4 4.9± 3.9 0.026
P&M CSA (mm2) 11.0± 4.4 9.5± 3.4 0.002
Plaque burden (%) 65± 8 66± 9 0.7
IVUS lesion length (mm) 22± 11 24± 9 0.3
Plaque morphology 0.3
Hypoechoic 142 (56) 60 (56)
Hyperechoic, non-calciﬁed 71 (28) 23 (21)
Hyperechoic, calciﬁed 33 (13) 20 (19)
Mixed 8 (3) 5 (5)
Remodeling index 1.00± 0.44 0.99± 0.34 0.8
Thrombus 61 (24) 30 (28) 0.3
Volumetric analysis
EEM volume (mm3) 403± 364 363± 270 0.001
Lumen volume (mm3) 206± 139 179± 129 0.029
3
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pPlaque volume (mm ) 197± 153
Data are n (%), or mean± SD. EEM, external elastic membrane; CSA
ultrasound.
When we compared the plaque components between
diabetic (n = 96) and nondiabetic patients (n = 266), %DC
and %NC volumes were signiﬁcantly greater in diabetic
patients compared with nondiabetic patients; conversely,
%FT and %FF volumes were signiﬁcantly smaller in
diabetic patients compared with nondiabetic patients
(Fig. 2A). When we compared the relative volumet-
ric plaque components between diabetic men (n = 59)
and diabetic women (n = 37), there were no signiﬁ-
cant differences in plaque components between both
groups (Fig. 2B). Also, when we compared the plaque
components between nondiabetic men (n = 195) and
nondiabetic women (n = 71), there were no signiﬁ-
cant differences in plaque components between both
groups.
When we compared the plaque components between
hypertensive (n = 210) and nonhypertensive patients
(n = 152), there were no signiﬁcant differences in plaque
components between both groups (%FT: 60.7± 10.7% vs
v
p
1
t
m183± 146 0.008
s-sectional area; P&M, plaque plus media; and IVUS, intravascular
9.8± 15.8%, p = 0.7; %FF: 12.5± 8.2% vs 13.2± 10.3%,
= 0.3; %DC: 10.6± 7.2% vs 9.7± 7.4%, p = 0.3; %NC:
6.3± 9.1% vs 17.3± 10.0%, p = 0.4). When we compared
he relative volumetric plaque components between hyper-
ensive men (n = 124) and women (n = 86), there were no
igniﬁcant differences in plaque components between
oth groups (%FT: 60.7± 10.2% vs 58.3± 11.2%, p = 0.11;
FF: 12.4± 7.9% vs 12.7± 8.6%, p = 0.8; %DC: 10.1± 6.4%
s 11.3± 8.3%, p = 0.2; %NC: 16.9± 8.6% vs 17.9± 9.8%,
= 0.5).
When we compared the plaque components between
lderly (≥70 years, n = 83) and nonelderly (<70 years,
= 279) patients, there were no signiﬁcant differences in
laque components between both groups (%FT: 59.2± 10.6%
s 60.0± 11.2%, p = 0.6; %FF: 12.2± 7.4% vs 13.2± 9.6%,
= 0.4; %DC: 11.0± 7.3% vs 9.9± 7.3%, p = 0.2; %NC:
7.6± 8.9% vs 17.0± 9.7%, p = 0.6). When we compared
he relative volumetric plaque components between elderly
en (n = 60) and elderly women (n = 23), there were
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Figure 1 The gender differences in the relative plaque com-
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Figure 2 The relative volumetric plaque components accord-
ing to the presence or absence of diabetes mellitus (A) and the
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betes, (2) women had smaller vessel size with smaller plaqueonents at the minimum lumen sites (A) and the volumetric
B) relative plaque components. FT, ﬁbrous; FF, ﬁbro-fatty; DC,
ense calcium; and NC, necrotic core.
o signiﬁcant differences in plaque components between
oth groups (%FT: 59.4± 10.4% vs 58.9± 11.4%, p = 0.9;
FF: 12.1± 7.0% vs 12.6± 8.5%, p = 0.8; %DC: 11.5± 7.5%
s 9.8± 6.9%, p = 0.3; %NC: 17.0± 8.4% vs 19.0± 10.1%,
= 0.4).
When we compared the plaque components between
atients with elevated hs-CRP (≥0.2mg/dl, n = 160) and
hose with normal hs-CRP levels (<0.2mg/dl, n = 202), %DC
nd %NC volumes were signiﬁcantly greater in patients with
levated hs-CRP compared with those with normal hs-CRP
evels (Fig. 3A). When we compared the relative volumet-
ic plaque components between men with elevated hs-CRP
n = 119) and women with elevated hs-CRP levels (n = 41),
here were no signiﬁcant differences in plaque components
etween both groups (Fig. 3B). Also, when we compared the
elative volumetric plaque components between men with
ormal hs-CRP (n = 135) and women with normal hs-CRP lev-
m
a
w
tender differences in the relative volumetric plaque compo-
ents in diabetic patients (B). FT, ﬁbrous; FF, ﬁbro-fatty; DC,
ense calcium; and NC, necrotic core.
ls (n = 67), there were no signiﬁcant differences in plaque
omponents between both groups.
ndependent predictors of TCFA
e performed multivariable analysis to determine the
ndependent predictors of culprit lesion TCFA. All the
ariables with p < 0.2 in univariable analysis (age, gen-
er, ST-segment elevation myocardial infarction, diabetes,
s-CRP, and P&M volume) were tested for multivari-
ble analysis. Diabetes [odds ratio (OR): 2.44, 95%
onﬁdence interval (CI): 1.35—3.82, p = 0.003] and hs-
RP (OR; 1.54, 95% CI = 1.08—2.65, p = 0.032), but not
emale gender, were the independent predictors of
CFA.
iscussion
he present VH-IVUS study demonstrated that (1) women
ad more risk factors such as old age, hypertension, and dia-ass in culprit lesion than men, (3) minimum lumen site DC
nd NC areas were signiﬁcantly greater in women compared
ith men, (4) although women had smaller plaque volume,
hey had greater DC and NC volumes compared with men, (5)
Gender differences in plaque components
Figure 3 The relative volumetric plaque components accord-
ing to high-sensitivity C-reactive protein levels (A) and the
gender differences in the relative volumetric plaque com-
ponents in patients with elevated high-sensitivity C-reactive
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of TCFA. Sixth, heavily calciﬁed plaques may induce anprotein levels (≥0.2mg/dl) (B). FT, ﬁbrous; FF, ﬁbro-fatty; DC,
dense calcium; and NC, necrotic core.
there was a trend toward higher incidence of TCFA in women
compared with men, and (6) independent predictors of TCFA
were diabetes and elevated hs-CRP, but not female gender.
Cardiovascular diseases are the major cause of morbid-
ity and mortality for both men and women, which occur
uncommonly in premenopausal women, but their incidence
rises sharply after the menopausal transition. Cardiovascular
gender differences are apparent long before cardiovascular
diseases appear in men and women, and improved under-
standing of the biology underlying these differences has the
potential to advance the diagnosis and treatment of cardio-
vascular diseases in both sexes [12].
Several studies reported that female gender itself was
an independent predictor of increased major adverse car-
diac event rate after percutaneous coronary intervention or
coronary artery bypass graft [19,20], while others did not
[21,22]. Women are affected with cardiovascular disease
at an older age than men, and many risk factors for coro-
nary heart disease have different distributions in men and
women [23—25]. In the present study, women were older and
had more hypertension and diabetes, which are consistent
with the results of the previous studies, and women had
more vulnerable plaque components than men. However,
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hese gender differences in plaque composition disappeared
n the same risk groups (diabetic patients, hypertensive
atients, elderly patients, and patients with elevated hs-
RP). Because women had more risk factors, they had
hances to have more vulnerable plaque components which
an cause worse outcomes than men. Predictors relating to
ulnerable plaque in the present study were diabetes and
s-CRP elevation, not female gender.
Morbidity and mortality in diabetic patients is markedly
igher than nondiabetic patients [26,27]. Worse outcome in
iabetic patients may be associated with endothelial dys-
unction and abnormality of vascular smooth muscle cell
unction, in addition to a propensity to thrombosis, which
ontribute to atherosclerosis and its complications [28,29].
revious studies showed diabetic patients had a larger con-
ent of lipid-rich plaque compared with nondiabetic patients
30], and inﬂammation and NC size play a greater role in
he progression of atherosclerosis in diabetic patients in
udden coronary death [31]. A previous study [32] showed
hat the absolute NC and DC volumes and %NC and DC
olumes were signiﬁcantly greater in diabetic patients com-
ared with nondiabetic patients; conversely, %FT and FF
olumes were signiﬁcantly smaller in diabetic patients com-
ared with nondiabetic patients, and diabetes mellitus was
he independent predictor of hs-CRP elevation and the pres-
nce of TCFA. An elevated CRP level is associated with
n increased risk of future ischemic complications in ACS
atients [33—35]. Another previous study demonstrated that
RP was associated with atherosclerosis in the arterial tree
36]. Several IVUS studies have demonstrated the associa-
ion between CRP and vulnerable plaque in ACS patients
37,38]. Burke et al. [39] reported the correlation between
RP and the number of TCFAs in patients who experienced
sudden death associated with severe coronary artery dis-
ase. Although it seems like that female ACS patients have
ore vulnerable plaque components compared with male
CS patients, it may result not from true gender differences
n plaque components but higher prevalence of other risk
actors such as diabetes and hs-CRP elevation in women than
n men.
tudy limitations
irst, the present study is a retrospective single-center
tudy, so, is subject to limitations inherent in this type of
linical investigation. Second, IVUS and VH-IVUS imaging
ere performed at the discretion of the individual oper-
tors leading to potential selection bias. Third, VH-IVUS
s a weak tool to detect vulnerable plaque. The reason
or that comes from the insufﬁcient spatial resolution of
ommercially available VH-IVUS. Fourth, we did not per-
orm three-vessel VH-IVUS. Therefore, we did not assess
he frequency of non-culprit lesion TCFAs. Fifth, we did
ot attempt to differentiate between atherosclerotic plaque
nd thrombus because VH-IVUS could not determine the
resence of thrombus. This may obscure the identiﬁcationrtifact regarding the codiﬁcation of plaques by VH-IVUS
esulting in an increase in NC content. Seventh, this study
opulation included patients with myocardial infarction. In
hese patients, the hs-CRP levels obtained before coronary
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ngiography may be inﬂuenced by myocardial tissue necro-
is. Eighth, we excluded the patients with serious conditions
uch as severe heart failure, cardiogenic shock, important
ystemic disease, or severe renal dysfunction. Thus, the
resent study might not reﬂect the real incidences of TCFA
nd the percentage of NC burden in whole ACS populations.
onclusions
lthough it seems likely that female ACS patients had more
ulnerable plaque components compared with male ACS
atients, these ﬁndings might result from higher prevalence
f diabetes and hs-CRP elevation in women.
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